Lo Y.WEI-HSIN WU2021-09-082021-09-0820201607-551Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85087719257&doi=10.1002%2fkjm2.12267&partnerID=40&md5=0b430878b3c08b6d2017074950028fb6https://scholars.lib.ntu.edu.tw/handle/123456789/582421[SDGs]SDG3amoxicillin plus clavulanic acid; C reactive protein; cisplatin; clobetasol propionate; D dimer; pemetrexed; prednisolone; antineoplastic agent; cisplatin; clobetasol; glucocorticoid; pemetrexed; aged; antibiotic therapy; case report; cellulitis; clinical article; desquamation; drug induced disease; drug withdrawal; eosinophil count; erythema; human; Letter; leukopenia; male; non small cell lung cancer; pseudocellulitis; rash; skin biopsy; stretching; wound healing; edema; leg; lung tumor; pathology; rash; treatment outcome; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clobetasol; Edema; Exanthema; Glucocorticoids; Humans; Leg; Lung Neoplasms; Male; Pemetrexed; Prednisolone; Treatment OutcomePemetrexed-induced pseudocellulitisletter10.1002/kjm2.12267326438632-s2.0-85087719257